Atlas Trials

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Clinical trial NCT00614640 · WITHDRAWN

Trial details

NCT number
NCT00614640
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HIV Infections
Primary completion
2013-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.